www.heartburncanceruk.org
## **HEARTBURN CANCER UK**
## **ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS**
**FOR THE YEAR ENDED 30 APRIL 2021**
**Company Registered Number: 07227937**
**Charity Registered Number: 1136413**
**14434421_1**
**HEARTBURN CANCER UK ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS**
|**YEAR ENDED 30 APRIL 2021**||
|---|---|
|**CONTENTS**|**PAGES**|
|Officers and professional advisers|**1**|
|Trustees' report|**2-7**|
|Independent examiner's report|**8**|
|Statement of financial activities|**9**|
|Balance sheet|**10**|
|Notes to the unaudited financial statements|**11 to 19**|
**HEARTBURN CANCER UK ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS**
## **YEAR ENDED 30 APRIL 2021**
## **OFFICERS AND PROFESSIONAL ADVISERS**
**Trustees** Mrs M E McCord Prof R C Fitzgerald Mr T Thornton-Jones Prof T J Underwood Mrs B A Huntingdon Mr P R Carr Mrs J R M Carr **Business address and registered office** Grove House Lutyens Close Chineham Court Basingstoke Hampshire RG24 8AG **Independent Examiner** Carmel Warren 22 Queens Ride Crowthorne Berkshire RG45 6LG
1
**HEARTBURN CANCER UK TRUSTEES' REPORT (Incorporating Directors' Report)**
## **YEAR ENDED 30 APRIL 2021**
The trustees present their report and the unaudited financial statements of the charitable company for the year ended 30 April 2021.
The unaudited financial statements have been prepared in accordance with the accounting policies set out in note 1 to the unaudited financial statements and comply with the charity's governing documents, The Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to small charities preparing their accounts in accordance with the Financial Reporting Standards applicable in the UK and Republic of Ireland (FRE 102)" (as amended for accounting periods commencing from 1 January 2016).
## **Objectives and Activities**
During the fiscal year 2020-21, Heartburn Cancer UK continued to work towards our well-defined mission and objectives as follows:
## **Mission**
To be a respected UK source of awareness and information on the risks of ignoring persistent heartburn, encouraging the public to seek medical advice, to champion research to enable an earlier diagnosis to save lives, and to support those living with reflux, Barrett’s oesophagus and oesophageal cancer .
## **Our Objectives**
For more information please visit our website at www.heartburncanceruk.org
## **Public Benefit**
The Trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake.
2
**HEARTBURN CANCER UK TRUSTEES' REPORT (Incorporating Directors' Report)** (continued)
## **YEAR ENDED 30 APRIL 2021**
## **Achievements and performance**
The Covid-19 pandemic has had a significant negative impact on all charities across the UK and wider world over the past 12 months. This has affected both our income levels as well as our plans to undertake awareness activities, as three UK lockdowns have prevented the UK populace from undertaking what might be considered a ‘normal’ life. As a result, our FY21 projected budget was quickly deemed inappropriate in early FY21, and we have striven since then to find other and creative ways to both raise funds as well as achieve the other key objectives of the charity.
Significantly, we have found new channels for funds, and have managed to increase our income compared to the previous year, albeit in a rather different shape; our plans to grow revenue by around 50% in FY21 have, though, proved difficult given the virus.
Fundraising
- Our tribute funds with Much Loved have worked well for people fundraising in memory of a loved one with an income of approximately £13,400 from 4 tributes.
- Plans to raise income from sponsorship for activities has been severely curtailed as those activities (Marathons etc) were cancelled. More recently, some supporters have adopted ‘virtual’ events as a means to raise funds, but these events were slow to launch after the initial shock of lockdowns being imposed, and so have had limited impact.
- We have been successful in attracting some medium-sized grants from various bodies which has enabled us to continue to operate for the benefit of heartburn sufferers without financial stress, and these grants, along with the other income streams, have ensured our income level in FY21 is on a par with that achieved in FY20 – a remarkable achievement considering the environment in which we have been forced to operate.
- Our first proper venture into merchandising, using our excellent new website platform, raised just over £1,100 at Christmas from the sale of cards to the public.
- The capability introduced with launch of the new website for online donations has seen approximately £9,500, including gift-aid, donated direct to date; this is a benefit to HCUK since the commission charged for processing is less than that charged by the likes of Just Giving and Virgin.
- We have embarked on our first ‘official’ corporate partnership with The Lanesborough Hotel in London. Two of their staff members and the husband of one of their senior team have lost their lives to oesophago-gastric cancers. They have named HCUK as their charity of choice and have already donated Christmas gift money which their staff have collected of around £1,000. Once they have reopened following lockdown, they have various thoughts about how they might work with HCUK to raise further funds .
- Partnerships were created with Make a difference cards, Charity Traveller, Discover Adventure and Much Loved. Much Loved have been the most successful to date. Holiday and adventure partnerships will hopefully become more relevant beyond the pandemic.
## Patient Support
- Support Groups affiliated to the charity were obviously impacted by restrictions on meeting in person. Despite this being a challenge throughout the pandemic, both London and East Anglia have continued their work, using virtual Zoom meetings.
- We received some funding to support the set up and administration of a new Patient Support Group on Facebook (Barrett’s and Oesophageal Cancer Online Support Group), which now has over 50 members, a significant proportion of whom are active and either requesting or providing advice on coping with symptoms and treatments.
3
**HEARTBURN CANCER UK TRUSTEES' REPORT (Incorporating Directors' Report)**
(continued)
## **YEAR ENDED 30 APRIL 2021**
## **Achievements and performance** _(continued)_
## Research and Diagnosis
- As the NHS re-deployed resources to cope with the enormous influx of Covid-19 patients, as well as imposing ‘clean regimes’ to prevent excess spread of the virus, services such as cancer-care were reduced and postponed. This has led to a perceived increase in the number of sufferers of heartburn who will not have been adequately diagnosed and treated; a timebomb as we defeat Covid-19 and return to a form of normality. We know that rates of endoscopy have been reduced dramatically, and inevitably this will lead to greater levels of incurable forms of the disease going forward. Endoscopic cancer detection reduced by 58% overall over a study period Jan to 31 May using the UK’s National Endoscopy Database by an NHS group.
- HCUK has worked with the Delta team, led by Prof Rebecca Fitzgerald, involved in development of the Cytosponge’ – a diagnostic tool less invasive and less expensive than an Endoscopy – to plan for a Mobile Diagnostic Unit and 1,500 tests in mid-2021 aimed at proving its value as well as saving lives. This represents the largest single investment in a project ever made by HCUK.
The construction and fit-out of the Mobile Diagnostic Unit commissioned and funded by the charity was completed just prior to the year end and the total costs of approximately £27,000 have been capitalised in the balance sheet. Deployment of the unit on the first phase of its involvement in the Delta project took place in early May 2021. This phase of the DELTA project is planned to take several months to complete and the outcome of that project will determine what the next steps will be for the Mobile Diagnostic Unit.
## General Awareness
- Following production of our first video campaign featuring ‘Mimi’s Story’ for the Hampshire campaigns in 2019 & early 2020, this was used again in a Sky AdSmart campaign during the early summer 2020 with the objective of raising money as well as achieving awareness of the dangers of ignoring persistent heartburn. Whilst we did see 130,000 impressions delivered amongst around 35,000 individual viewers, the fundraising objective (‘text donate’) was unsuccessful.
- Our social media presence has been the focus of 2020 into early 2021, and we’ve seen great increases in our followers, friends etc on Facebook, Twitter, LinkedIn and Instagram, with regular and informative posts. We continue to work with an external provider to ensure regular and timely Social Media output, and this is expected to continue.
- Towards the end of the year we produced our second video, with additional audio file for radio campaigns, which takes the stories of 3 heartburn sufferers who were caught in time to save their lives, as well as the thoughts of a Specialist Research Nurse. This is the so-called ‘Happy Outcome’ campaign, to be used going forward on Social Media, Radio and possibly TV.
- Our website redevelopment in late FY20 has provided a fabulous platform for communication, and is seeing major uplift in visitors. We continued to exploit opportunities using the site, especially online merchandising and the sale of our Christmas Cards, generously donated to us by a print partner.
- Other planned awareness campaigns in the NW, London and Scotland were necessarily shelved given the absence of footfall in outdoor locations for viewing, in addition to a desire not to cause unnecessary worry amongst the general public as it became much more difficult and in some cases impossible to see a GP or to access an endoscopic examination in lockdown.
4
**HEARTBURN CANCER UK TRUSTEES' REPORT (Incorporating Directors' Report)** (continued)
## **YEAR ENDED 30 APRIL 2021**
## **Achievements and performance** _(continued)_
In summary, despite the challenges posed to charitable organisations around the world by the Covid 19 pandemic, HCUK has managed to sustain its income, albeit in an atypical manner, whilst investing both time and financially in the exciting Mobile Diagnostic Unit, which will be the focus of our awareness and support activity throughout FY22 and beyond. Pure awareness activity was limited in 2020 to our TV campaign as well as social media, particularly due to Covid-19 lockdowns and therefore the unsuitability of outdoor campaigns to spread our message.
## **Financial Review**
Total reserves are £126,438 (2020: £106,302), of this £40,248 is restricted and within restricted funds are held the fixed asset balance for the Mobile Diagnostic Unit. See note 17 for the detailed descriptions and balances on these funds.
It is the policy of the charity that unrestricted funds, which have not been designated for a specific use should be maintained at a level equivalent to six months's expenditure, which is calculated to be in the region of £35,000. The Trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity's current activities whilst consideration is given to ways in which additional funds may be raised. This level of reserves has been maintained throughout the year.
## **Risks**
The Trustees have assessed the major risks to which the charity is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks.
## **Plans for the future**
Our major focus, for the forthcoming financial year to April 2022, is executing a successful Mobile Diagnostic Unit Pilot with Project Delta and maximising all opportunities for fundraising, general awareness and positive PR on this very tangible ‘make a real difference’ initiative. Leaving this new geographic area with lasting GP and Pharmacy relationships for awareness and support of the public living with reflux, Barrett’s or oesophageal cancer. We have a fantastic opportunity for new collaborations this year as a result of the work undertaken, which should make it much more straightforward to expand our messages of awareness wider in the UK.
Resources-permitting we are also planning to re-schedule the outdoor awareness campaigns shelved due to the pandemic in 2020. These are likely to be undertaken in the NW & NE of England as well as Scotland, where we know that the prevalence of undiagnosed Barrett’s and oesophageal cancer is higher than the UK average.
Meanwhile we will finalise our fundraising strategy and delivering against our plans, continue with initiatives that have worked well for us and progress new ideas as we start being released from the pandemic.
We will continue to encourage people to seek current information and guidance from our website ‘our shop window’ and encourage them to get involved to support us whenever we can. We will actively do this through all awareness activity, PR and social media. We again intend to double our social media following on all platforms in the year ahead.
We plan to maximise opportunities from our website. Our Google Adwords account will be moved to a new partner in June 2021, with the aim of enhancing our visitor numbers for support as well as fundraising.
It’s important to continue our patient support activity. Patients contact the office by phone or email or they find us on or through our more traditional support groups. We are investigating cost effective methods of developing this further, especially in instances where patients can help and advise each other from the perspective of their personal experiences. We are also ready to start new groups in areas where there is a need, most probably commencing in regions where we deploy the Mobile Diagnostic Unit.
5
## **HEARTBURN CANCER UK TRUSTEES' REPORT (Incorporating Directors' Report)**
(continued)
## **YEAR ENDED 30 APRIL 2021**
## **Structure, governance and management**
The following served as trustees during the year:
Mrs M E McCord Mr A R Cheyne OBE Prof R C Fitzgerald Mr T Thornton-Jones Prof T J Underwood Mrs B A Huntingdon Mr P R Carr Mrs J R M Carr
(deceased 8 May 2020)
The above are also Directors for the purposes of company law.
The Board have the statutory power to appoint new trustees under the terms of the Trust Deed and provide the necessary training in order that they may fulfil their obligations as Trustees.
None of the Trustees has any beneficial interest in the company. The Directors, are members of the company and guarantee to contribute £1 in the event of a winding up.
The charity is governed by the Board of Trustees which is responsible for formulating the strategies and policies of the charity including exercising financial controls.
## **Trustees' responsibilities**
The Trustees are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and regulations.
Company law requires the Trustees to prepare financial statements for each financial year. Under that law the Trustees have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, incuding the statement of financial acitvities of the charitable company for that year. In preparing these financial statements, the Trustees are required to:
- select suitable accounting policies and then apply them consistently;
- make judgements and estimates that are reasonable and prudent;
- observe the methods and principles in the Charities SORP;
- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the accounts; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in operation.
6
HEARTBURN CANCER UK
TRUSTEES. REPORT {Incorporating Directors. Report)
Icontinuedl
YEAR ENDED 30 APRIL 2021
The Trustees are responsible for keeping proper accounting records that are sufficient to show and explain
the charitable company's transactions and disclose with reasonable accuracy at any time the financial
position of the charitable company and enable them to ensure that the fiftancial statèmonts comply with
the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company
and hence for taking reasonable step5 for the prevention and detection of fraud and other irregularities.
This report has been prepared in accordance with the provisions applicable to companies entitled to the
small companies exemption.
Signed on behalf of the Board of Tru5tee5
Mrs M E Mccord
Chair of Trustees
Approved by the board on..
io ZOZI
INDEPENDETrTh EXAMINER'S REPORT TO THE TRUSTEE5 OF
HEARTBURN CANCER UK
YEAR ENDED 30APRIL2021
I report on the financial statements of the chartty for the year ended 30 April 2021. which are set out on
pages 9 to Ig.
Respectlve responsibilities of Trustee5 and examiner
The charity's Trustees, who a a150 the director5 of Heartburn Cancer UK for the purposes of company
law, are responsible for the preparation of the accounts. The Trustees consider that an audit is not
required for thi5 year under section 144121 of the Charities Art 2011 (the 2011 Act) and that an
independent examination 15 needed.
Having satisfied myself that the charity is not subject to audit under company law and is eligible for
independent examination, it is my responsibility to=
lil examine the financial statements under section 145 of the 2011 Act-
lill to follow the procedures13id down in the general Dirertion given by the Charity Commission under
section 1451Sllbl of the 2011 Act: and
11111 to state whether particular matters have come to my attention.
Basis of Independent examinels report
My examination was carfied out in accordance with the general Direction5 given by the Charity
Commission. An examination includes a review of the accounting records kept by the charity and a
comparison of the financial statements presented wf(h those records. It also include5 consideration of
any unusual items or disclosures in the financial statements, and seeking explanations from you as
trustees concerning any such matters. The procedures undertaken do not provide all the evidence th8t
would be required in an audit and consequently no opinion is given as to whether the financial
statements present a 'true and fair view, and the report 15 limTted to those matters set out in the next
statements.
Independent examinerfs statement
In connection with my examination, no matter has come to my attention-.
lal which gives me reasonable cause to believe that in any material respect the requirements..
lil to keep accounting records in accordance with section 386 of the Companies Act 2006.and
lill to prepare financial statements which accord with the accounting records, comply with the
accounting requirements of section 396 of the companies Act 2006 and with the method5 and
principle5 of the statement of Recommended Practice Accounting and Reporting by Charities;
have not been met.. or
Ibl to which, in my opinion. attention should be drawn in order to enable a proper understanding of
the financial statements to be reached.
Cam)el Warren
22 Queens Ride
Crowthorne
Berkshire
RG45 6LG
Date..
io 20zI
## **HEARTBURN CANCER UK STATEMENT OF FINANCIAL ACTIVITIES including INCOME AND EXPENDITURE ACCOUNT YEAR ENDED 30 APRIL 2021**
|**General Designated**
**Notes**
**Income from:**
Donations and legacies
2
75,148
-
Fundraising activites
3
1,138
-
Investments
4
41
-
**Total incoming resources**
76,327
-
**Expenditure on:**
Costs of generating funds
5
28,253
-
Charitable activities
6
45,860
-
Governance costs
10
48
-
**Total resources expended**
74,161
-
**Net income/(expenditure) for the**
**year/net movement in funds**
2,166
-
**Fund balances as at 1 May 2020**
84,024
-
**Fund balances as at 30 April 2021**
17
86,190
-
**Unrestricted funds**|**Restricted**
**funds**
47,970
-
-
47,970
-
30,000
-
30,000
17,970
22,278
40,248|**2021**
**£**
123,118
1,138
41
124,297
28,253
75,860
48
104,161
20,136
106,302
126,438|_2020_
_£_
_94,353_
_-_
_113_|
|---|---|---|---|
||||_94,466_
_20,276_
_64,938_
_78_|
||||_85,292_|
||||9,174
_97,128_|
||||_106,302_|
The statement of financial activities includes all gains and losses recognised in the year
All income and expenditure relates to continuing activities.
The statement of financial activities also complies with the requirements of an income and expenditure account under the Companies Act 2006
The notes on pages 11 to 19 form part of these financial statements.
9
HEARTBURN CANCER UK
BALANCE SHE
Reoistered Nufflber 07227937
AS AT 30 APRIL 2021
2021
2020
Note
14
Fixed Assets
27,058
27,058
Current Assets
Other debtors
Cash at bank and in hand
7,203
92.735
99.938
9.999
100,819
110,818
Creditors: Amounts falling due within one
year
16
15581
14,516J
Net current assets
99,380
106,302
Total asset5 less current liabllitles
126.438
106,302
Net assets
126.438
106,302
Represented by:
Intome Funds
Restricted funds
Unrestricted Funds
Designated fund5
General unrestricted funds
17
40.248
22,278
17
17
86,190
84,024
126,438
106.302
The charitable company is entitled to the exemption from the audit requirement contained in section 477
of the Companies Act 2006. for the year ended 30 April 2021. No member of the charitable company has
deposited a notice, pursuant to secuon 476, requiring an audit of these financial statements.
The Trustees acknowledge their responsibilities for complying with the reqirements of the Companies Act
with respect to accounting records and the preparation of accounts.
These financial statements have been prepared in accordance with the provisions applicable to
companies subject to the small companies regime and in accordance wrth FRS102 SORP.
These financial statements were approved by the Tmstees and authorised for i55ue on
and are si8ned on their behalf by..
io zoZL
Mrs M E Mccord
Chair of Trustees
The notes on pages 11 to 19 form part of these financial statements.
io
**HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS**
## **YEAR ENDED 30 APRIL 2021**
## **1 Accounting policies**
## **General information**
Heartburn Cancer UK ("the charitable company") has prepared financial statements covering its results for the year to 30 April 2021. The charitable company has presented its financial statements in Sterling, rounded to the nearest whole pound.
The charitable company is a private company limited by guarantee and is incorporated in England and Wales. The address of the charitable company's registered office is presented on page 1 of these financial statements under Officers and Professional Advisors. The charitable company's principal activities and nature of the business are shown on page 2.
## **Basis of accounting**
The financial statements have been prepared under the historical cost convention, in accordance with the charity's governing document, the Companies Act 2006, as applicable to companies subject to the small companies regime, "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with FRS102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" ("SORP") and with the Charities Act 2011. The principal accounting policies adopted are set out below.
The charity is a Public Benefit Entity as defined by FRS 102.
## **Statement of Cashflows**
The charitable company has taken advantage of the provisions in the SORP for charities applying FRS102 update Bulletin 1 not to prepare a Statement of Cashflows.
## **Going concern**
At the time of preparing the financial statements, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existance for the forseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
## **Charitable Funds**
Unrestricted funds are available for use at the discretion of the Trustees in furtherence of their charitable objectives unless the funds have been designated, by the Trustees, for other purposes.
Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.
Endowment funds are subject to specific conditions by donor that the capital must be maintained by the charity.
## **Incoming resources**
Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.
Donations by way of grants are recognised either on receipt or Invoice, whichever is earlier.
Donations and associated gift aid from on-line sites such as Just Giving and Virgin Giving are recognised as and when paid by those sites, after they have been verified and processed, and includes donations remitted to the charity from those sites within the financial year. These donations are recorded net of processing charges.
Other donations and legacies are recognised on receipt. Income tax recoverable in relation to donations received under Gift Aid is recognised at the time of the donation.
Donated services and facilities are included in the Statement of Financial Activities in the year they are received at the value of the gift to the charity, provided the value of the gift can be measured reliably. The expense element of such donations is reflected in resources expended in the appropriate expense category.
11
**HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS**
## **YEAR ENDED 30 APRIL 2021**
## **1 Accounting policies** (continued)
## **Resources expended**
Costs of generating voluntary income comprise the costs incurred by the charity to induce others to make donations to the charity.
Activities in furtherance of charitable objectives undertaken directly relate to expenditure incurred as a direct result of undertaking the charitable objectives of the charity.
## **Governance and core activities expenditure**
Governance costs comprise all costs involving public accountability of the charity and its compliance with regulation and good practice.
Core Activities Expenditure are those costs incurred directly in support of the objects of the charitable company and fundraising and are allocated to activity cost categories on a basis consistent with the use of resources.
## **Tangible fixed assets**
Tangible fixed assets are stated at cost less depreciation. Cost represents purchase price together with any incidental costs of acquisition.
## **Depreciation**
Depreciation is calculated so as to write off the cost of an asset, net of anticipated disposal proceeds, over the useful economic life of that asset as follows:
- Mobile Diagnostic Unit straight line over 5 years
## **Financial Instruments**
The charitable company only has financial assets and liabilites of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measure at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
## **Critical accounting estimates and areas of judgement**
In the application of the charity's accounting policies, the Trustees are requried to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimated and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
12
**HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS**
## **YEAR ENDED 30 APRIL 2021**
|**2**
**Donations and legacies**
**Unrestricted **
**funds**
Donations and gifts
64,574
Donations in Kind
10,574
75,148
**3**
**Fundraising activites**
Sale of Christmas Cards
**4**
**Investments**
Interest receivable
**5**
**Costs of generating funds**
Printing and advertising
Website and social media
Fund raising activities
Other expenditure
See note 8 for further details
**6**
**Expenditure on Charitable Activities**
**Unrestricted **
**funds**
Grant funding of activities
-
Other expenditure
45,860
45,860
_Analysis by fund for 2020_
_41,433_
**7**
**Grants payable**
**Unrestricted **
**funds**
HCUK East Anglia
**-**
To fund a surgical specialty lead
**-**
Other grants
-
-|**Designated**
**funds**
**-**
**-**
-
**Designated**
**funds**
-
-
-
_2,500_
**Designated**
**funds**
**-**
**-**
-
-|**Restricted**
**funds**
47,970
**-**
47,970
**Restricted**
**funds**
7,500
22,500
30,000
_21,005_
**Restricted**
**funds**
-
7,500
-
7,500|**2021**
**£**
112,544
10,574
123,118
**2021**
**£**
1,138
**2021**
**£**
41
**2021**
**£**
1,233
1,296
2,714
23,010
28,253
**2021**
**£**
7,500
68,360
-
75,860
_64,938_
**2021**
**£**
-
7,500
-
7,500|_2020_
_£_
_84,309_
_10,044_|
|---|---|---|---|---|
|||||_94,353_|
|||||_2020_
_£_
_-_|
|||||_2020_
_£_
_113_|
|||||_2020_
_£_
_1,773_
_500_
_2,127_
_15,876_|
|||||_20,276_|
|||||_2020_
_£_
_12,739_
_52,199_
_-_|
|||||64,938|
|||||_2020_
_£_
_239_
_7,500_
_5,000_|
|||||_12,739_|
13
**HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS**
## **YEAR ENDED 30 APRIL 2021**
|**8**
**Core activities expenditure analysis for the year**
**Fundraising**
**Awareness**
**Research**
**Support**
**Groups**
**£**
**£**
**£**
**£**
Staff costs
17,808
13,992
7,518
4,972
Travel costs and training
75
-
-
-
Grants awarded
-
-
7,500
-
Office space
3,539
2,780
1,494
988
Printing and advertising
1,233
11,098
-
-
Website and social media
1,296
11,666
-
-
IT and computer expenses
903
709
381
252
Postage, courier and telephone
184
144
78
51
Fundraising
2,714
-
-
-
Office supplies
20
15
8
5
Insurance
-
-
-
-
Bank charges
446
-
-
-
Subscriptions
-
-
-
-
Sundries
-
-
-
-
Regulatory and governance costs
35
-
-
-
28,253
40,404
16,979
6,268
**Total expended resources for the year to 30 April 2021**
**9**
**Allocation of costs to funds**
**2021**
**£**
**£**
**£**
**£**
**Unrestricted Designated**
**Restricted**
Staff Costs
53,212
32,212
-
21,000
Travel costs
75
75
-
-
Grants awarded
7,500
-
-
7,500
Office space
10,574
10,574
-
-
Printing and advertising
12,331
11,331
-
1,000
Website and social media
12,962
12,462
-
500
IT and computer expenses
2,697
2,697
-
-
Postage, courier and telephone
549
549
-
-
Fundraising
2,714
2,714
-
-
Office supplies
59
59
-
-
Insurance
444
444
-
-
Bank charges
590
590
-
-
Subscriptions
120
120
-
-
Sundries
286
286
-
-
Regulatory and governance costs
48
48
-
_-_
104,161
74,161
-
30,000
**2021 Allocation**|**General**
**support**
**£**
8,922
-
-
1,773
-
-
452
92
-
11
444
144
120
286
13|
|---|---|
||12,257|
||104,161|
||_2020_
_£_
_32,653_
_668_
_12,739_
_10,858_
_17,732_
_4,998_
_1,003_
_1,191_
_2,127_
_104_
_444_
_276_
_125_
_246_
_128_|
||_85,292_|
Costs are allocated to funds on the basis of either actual costs incurred or estimated resource usage.
14
**HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS**
## **YEAR ENDED 30 APRIL 2021**
|**10 Governance Costs**
Legal and Professional fees
Independent examiner's fee
**11 Staff costs**
Salaries and wages
Pension costs
No staff receive more than £60,000 per annum.
Average number of full time equivalent staff in the year
Fundraising
Charitable activities
Other
Average (absolute) number of staff in the year|**2021**
**£**
48
-
48
**2021**
**£**
52,084
1,128
53,212
**2021**
**FTE No**
0.6
0.8
0.3
1.7
**2021**
**No**
3.0|_2020_
_£_
_48_
_30_|
|---|---|---|
|||_78_|
|||_2020_
_£_
32,157
496|
|||_32,653_|
|||_2020_
_FTE No_
_0.4_
_0.5_
_0.2_|
|||_1.1_|
|||_2020_
_No_
_2.4_|
## **12 Trustees**
None of the Trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year.
15
**HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS**
## **YEAR ENDED 30 APRIL 2021**
## **13 Related Party Transactions**
During the year Absolutely Offices Limited, of which Beryl Huntingdon, a trustee of the charitable company, is a director, provided the following services to the charity on normal commercial terms.
|Computer expenses
Postage, courier and telephone
Office supplies and sundry expenses
Office space
Printing and advertising|**2021**
**£**
196
-
-
41
237|_2020_
_£_
_-_
_873_
_120_
_814_
_-_|
|---|---|---|
|||_1,807_|
In addition, Absolutely Offices Limited provided the following services free of charge as a donation in kind:
|Office space
**Tangible fixed assets**
**Cost**
At 1 May 2020
Additions
At 30 April 2021
**Depreciation**
At 1 May 2020
Charge for the period
At 30 April 2021
**Net book value**
At 30 April 2021
_At 1 May 2020_|**2021**
**£**
10,044
10,044
**£**
-
27,058
27,058
-
-
-
27,058
_-_
**Mobile**
**Diagnostic**
**Unit**|_2020_
_£_
_10,044_|
|---|---|---|
|||_10,044_|
|||**Total**
**£**
-
27,058
-|
|||27,058|
|||-
-
-|
|||-|
|||27,058|
|||_-_|
## **14 Tangible fixed assets**
16
**HEARTBURN CANCER UK NOTES TO THE UNAUDITED FINANCIAL STATEMENTS**
## **YEAR ENDED 30 APRIL 2021**
|**15 Other debtors**
Other debtors
Prepayments and accrued income
**16 Creditors:** **Amounts falling due within**
**one year**
Trade creditor
Other creditor - pension creditor
Accruals and deferred income
**17 Statement of Funds**
**Unrestricted Funds**
**Designated Funds**
**General Funds**
Total unrestricted funds|**Balance at**
**1 May**
**2020**
**£**
-
-
84,024
84,024|**2021**
**£**
-
7,203
7,203
**2021**
**£**
324
234
-
558
**Incoming**
**resources**
**Resources**
**expended**
**Transfers**
**£**
**£**
**£**
-
-
-
-
-
-
76,327
(74,161)
-
76,327
(74,161)
-
**Movement in Funds**|_2020_
_£_
_9,600_
_399_|
|---|---|---|---|
||||9,999|
||||_2020_
_£_
_57_
_84_
_4,375_|
||||4,516|
||||**Balance at**
**30 April**
**2021**
**£**
-|
||||-|
||||86,190|
||||86,190|
17
**HEARTBURN CANCER UK**
**NOTES TO THE UNAUDITED FINANCIAL STATEMENTS**
## **YEAR ENDED 30 APRIL 2021**
## **17 Statement of Funds (continued)**
|**Restricted Funds**
HCUK Augis RCS
Cytosponge Mobile Diagnostic Unit
Staff Costs - Covid crisis period
Return to fitness
Awareness - North West of England
Awareness - London
Peer Support Network
HCUK East Anglia
Awareness|**Balance at**
**1 May**
**2020**
**£**
10,625
-
6,400
1,000
2,102
-
-
2,151
-
22,278|**Incoming**
**resources**
**Resources**
**expended**
**£**
**£**
-
(7,500)
31,370
14,600
(21,000)
-
-
-
-
500
-
500
(500)
-
-
1,000
(1,000)
47,970
(30,000)
**Movement in Funds**|**Balance at**
**30 April**
**2021**
**£**
3,125
31,370
-
1,000
2,102
500
-
2,151
-|
|---|---|---|---|
||||40,248|
## **HCUK Augis Royal College of Surgeons**
To help fund a Surgical Speciality Lead in the field of Oesophageal Cancer
## **Cytosponge Mobile Diagnostic Unit**
To fund the purchase of a Mobile Diagnostic Unit and related equipment, which are accounted for as fixed assets and will be depreciated from May 2021, and fund the running costs of the unit. The unit is currently being deployed to support the DELTA project to demonstrate the efficacy of the "Cytosponge" in promoting early diagnosis of Oesophageal Cancer and/or Barrett's Oesophagus.
## **Staff costs during the Covid Crisis period**
To fund staff costs during the Covid crisis period.
## **Return to fitness**
To support a research project into a programme to support Oesophageal Cancer patients recovering after treatment.
## **Awareness - North West of England**
Fund to raise awareness in patients and physicians of the link between persistent heartburn and Oesophageal Cancer and/or Barrett's Oesophagus, in the North West of England.
## **Awareness- London**
Fund to raise awareness in patients and physicians of the link between persistent heartburn and Oesophageal Cancer and/or Barrett's Oesophagus, in the London area.
## **Peer Support Network**
To fund support networks for patients diagnosed with Oesophageal Cancer and/or Barrett's Oesophagus.
## **HCUK East Anglia**
To fund the activities of the East Anglia support group with funds generated by the support group itself.
## **Awareness**
Fund to raise awareness in patients and physicians of the link between persistent heartburn and Oesophageal Cancer and/or Barrett's Oesophagus.
18
**HEARTBURN CANCER UK**
**NOTES TO THE UNAUDITED FINANCIAL STATEMENTS**
## **YEAR ENDED 30 APRIL 2021**
## **18 Analysis of net assets between funds**
|**Analysis of net assets between funds**||||
|---|---|---|---|
|**Unrestricted **
**funds**
Fund balances at 30 April 2021 are
respresented by:
Fixed Assets
-
Net current assets
86,190
Net assets
86,190|**Designated**
**funds**
-
-
-|**Restricted**
**funds**
27,058
13,190
40,248|**Total**
**£**
27,058
99,380|
||||126,438|
## **19 Ultimate controlling party**
The trustees do not consider there to be an ultimate controlling party other than the Board of Trustees.
19